Biote Corp. logo

Biote Corp. (BTMD)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
2. 43
+0.05
+2.1008%
$
96.6M Market Cap
46.31 P/E Ratio
- Div Yield
298,400 Volume
0.32 Eps
$ 2.38
Previous Close
Add Transaction
Day Range
2.29 2.53
Year Range
1.27 4.75
Want to track BTMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BTMD closed today higher at $2.43, an increase of 2.1008% from yesterday's close, completing a monthly increase of 29.9465% or $0.56. Over the past 12 months, BTMD stock lost -6.8966%.
BTMD is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2026, missed the consensus estimates by -0.0967%. On average, the company has fell short of earnings expectations by -0.0338%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

BTMD Chart

People also search for

AirSculpt Technologies Inc.
$ 4.45
+6.9712%
Veraxa Biotech Holding AG
$ 2.18
+6.3415%
Cellectis S.A. - ADR
$ 2.63
-1.4981%
Sutro Biopharma, Inc.
$ 23.57
-0.6743%
Turn Therapeutics Inc.
$ 9.12
+0.9967%
biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

biote Corp. (BTMD) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.08 per share a year ago.

Zacks | 2 months ago
biote Corp. (BTMD) Q4 Earnings and Revenues Top Estimates

biote Corp. (BTMD) Q4 Earnings and Revenues Top Estimates

biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.1 per share a year ago.

Zacks | 4 months ago

Biote Corp. Investors

Name Quantity Cost Value Profit ($) Gain (%)
CE
Curtis Ellergodt Rothschild Investment LLC
6 $16 $13.56 -$2.44 -15.25%
Joseph Castro
Joseph Castro Nuveen LLC
36,459 $121,408.47 $82,032.75 -$39,375.72 -32.43%
Michael Braner
Michael Braner 325 Capital LLC
4.55M $28.7M $10.28M -$18.42M -64.19%
Bobby Adusumilli
Bobby Adusumilli SJS Investment Consulting Inc.
3 $4.05 $6.39 $2.34 57.78%
Amna Ali Khan
Amna Ali Khan GDS Wealth Management
42,789 $319,633.83 $96,917.08 -$222,716.75 -69.68%

Biote Corp. (BTMD) FAQ

What is the stock price today?

The current price is $2.43.

On which exchange is it traded?

Biote Corp. is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is BTMD.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 96.6M.

Has Biote Corp. ever had a stock split?

No, there has never been a stock split.

Biote Corp. Profile

Biotechnology Industry
Healthcare Sector
Bret Christensen CEO
NASDAQ (NMS) Exchange
090683103 CUSIP
US Country
223 Employees
- Last Dividend
- Last Split
28 Apr 2021 IPO Date

Overview

Biote Corp. is a company deeply embedded in the hormone optimization industry. It specializes in a niche yet crucial aspect of healthcare—hormone optimization, focusing primarily on the use of bioidentical hormone replacement pellet therapy to address hormonal imbalances in both men and women. Biote stands out in the market by offering a comprehensive platform known as the Biote Method. This platform not only involves educating, training, and certifying healthcare professionals such as physicians and nurse practitioners but also extends to providing robust practice management solutions. These solutions are designed to streamline the operations of practitioners who specialize in hormone optimization, empowering them to better manage their inventory, patient data, and overall administrative tasks with greater efficiency. Established in 2012, Biote Corp. has positioned its headquarters in Irving, Texas, marking its presence in the medical field by focusing on an area that directly impacts the wellbeing and quality of life of its patients.

Products and Services

  • Biote Method

    This flagship offering encompasses a full range of services aimed at building and enhancing the practices of hormone optimization specialists. It includes education, training, and certification for practitioners, covering the latest in hormone optimization therapies and best practices. Beyond enhancing professional expertise, the Biote Method extends into comprehensive practice management software. This software solution is designed for the seamless ordering, tracking, and management of hormone optimization product inventories, as well as other administrative tasks, helping certified practitioners optimize their practice operations.

  • Practice Management Software

    Integral to the Biote Method, this software is specifically tailored to the needs of hormone optimization professionals. It enables Biote-certified practitioners to efficiently manage their practice by streamlining the process of ordering, tracking, and managing both hormone optimization product inventory and patient-related administrative requirements. Its user-friendly interface and specialized features make it an indispensable tool for practitioners looking to simplify their workflow and focus more on patient care.

  • Inventory Management Software

    Another facet of Biote's technological offerings, this software is focused on managing pellet inventory—a key component in hormone replacement therapy. It ensures that practitioners can keep an accurate account of their hormone pellet stock levels, thereby avoiding shortages or overstock situations. This system is especially critical for maintaining the continuity of therapy sessions, ensuring that patients' treatments proceed without interruption.

  • Dietary Supplements

    Biote extends its brand into the realm of dietary supplements, offering products specifically designed to support the hormone optimization process. These supplements are marketed under the Biote brand, aligning with the company's commitment to providing a holistic approach to hormone health.

  • Sterile Pellet Insertion Kits

    As part of its comprehensive approach to hormone optimization, Biote also provides sterile pellet insertion kits. These kits are essential for the safe and effective administration of hormone pellets, used in conjunction with hormone optimization therapies for both male and female patients. The kits underscore Biote’s commitment to ensuring that practitioners have access to high-quality, reliable supplies necessary for delivering treatment.

Contact Information

Address: 1875 West Walnut Hill Lane
Phone: 844-604-1246